Research Advisory Committee on Gulf War Veterans' Illnesses; Notice of Meeting, 51400 [2014-20484]

Download as PDF pmangrum on DSK3VPTVN1PROD with NOTICES 51400 Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices (Other than Temporomandibular Joint Conditions) Disability Benefits Questionnaire, VA Form 21–0960–D–1. g. Endocrine Diseases (other than Thyroid, Parathyroid or Diabetes Mellitus) Disability Benefits Questionnaire, VA Form 21–0960–E–2. h. Thyroid & Parathyroid Conditions Disability Benefits Questionnaire, VA Form 21–0960–E–3. l. Hernias (Including Abdominal, Inguinal, and Femoral Hernias) Disability Benefits Questionnaire, VA Form 21–0960–H–1. m. HIV-Related Illnesses Disability Benefits Questionnaire, VA Form 21– 0960–I–2. n. Infectious Diseases (other than HIVRelated Illness, Chronic Fatigue Syndrome, and Tuberculosis) Disability Benefits Questionnaire, VA Form 21– 0960I–3. o. Systemic Lupus Erythematosus (SLE) and Other Autoimmune Diseases Disability Benefits Questionnaire, VA Form 21–0960–I–4. p. Nutritional Deficiencies Disability Benefits Questionnaire, VA Form 21– 0960–I–5. q. Urinary Tract (including Bladder & Urethra) Conditions (excluding Male Reproductive System) Disability Benefits Questionnaire, VA Form 21– 0960–J–4. r. Respiratory Conditions (other than Tuberculosis and Sleep Apnea) Disability Benefits Questionnaire, VA Form 21–0960–L–1. s. Loss of Sense of Smell and/or Taste Disability Benefits Questionnaire, VA Form 21–0960–N–3. t. Sinusitis/Rhinitis and Other Conditions of the Nose, Throat, Larynx, and Pharynx Disability Benefits Questionnaire, VA Form 21–0960–N–4. u. Chronic Fatigue Syndrome Disability Benefits Questionnaire, VA Form 21–0960–Q–1. OMB Control Number: 2900–0781. Type of Review: Revised collection. Abstract: Data collected on VA Form 21–0960 series will be used obtain information from claimants treating physician that is necessary to adjudicate a claim for disability benefits. Affected Public: Individuals or households. Estimated Annual Burden: 53,750 hours. (a) VAF 21–0960–C–3—5,000 (b) VAF 21–0960–C–6—1,250 (c) VAF 21–0960–C–7—1,250 (d) VAF 21–0960–C–11—1,250 (e) VAF 21–0960–D–1—1,250 (f) VAF 21–0960–E–2—2,500 (g) VAF 21–0960–E–3—2,500 (h) VAF 21–0960–H–1—3,750 (i) VAF 21–0960–I–2—1,250 VerDate Mar<15>2010 14:14 Aug 27, 2014 Jkt 232001 (j) VAF 21–0960–I–3—2,500 (k) VAF 21–0960–I–4—2,500 (l) VAF 21–0960–I–5—1,250 (m) VAF 21–0960–J–4—3,750 (n) VAF 21–0960–L–1—10,000 (o) VAF 21–0960–N–3—1,250 (p) VAF 21–0960–N–4—10,000 (q) VAF 21–0960–Q–1—2,500 Estimated Average Burden per Respondent: (a) VAF 21–0960–C–3—30 minutes (b) VAF 21–0960–C–6—15 minutes (c) VAF 21–0960–C–7—15 minutes (d) VAF 21–0960–C–11—15 minutes (e) VAF 21–0960–D–1—15 minutes (f) VAF 21–0960–E–2—15 minutes (g) VAF 21–0960–E–3—15 minutes (h) VAF 21–0960–H–1—15 minutes (i) VAF 21–0960–I–2—15 minutes (j) VAF 21–0960–I–3—15 minutes (k) VAF 21–0960–I–4—30 minutes (l) VAF 21–0960–I–5—15 minutes (m) VAF 21–0960–J–4—15 minutes (n) VAF 21–0960–L–1—30 minutes (o) VAF 21–0960–N–3—15 minutes (p) VAF 21–0960–N–4—30 minutes (q) VAF 21–0960–Q–1—15 minutes Frequency of Response: On occasion. Estimated Number of Respondents: TOTAL: 160,000. (a) VAF 21–0960–C–3—10,000 (b) VAF 21–0960–C–6—5,000 (c) VAF 21–0960–C–7—5,000 (d) VAF 21–0960–C–11—5,000 (e) VAF 21–0960–D–1—5,000 (f) VAF 21–0960–E–2—10,000 (g) VAF 21–0960–E–3—10,000 (h) VAF 21–0960–H–1—15,000 (i) VAF 21–0960–I–2—5,000 (j) VAF 21–0960–I–3—10,000 (k) VAF 21–0960–I–4—5,000 (l) VAF 21–0960–I–5—5,000 (m) VAF 21–0960–J–4—15,000 (n) VAF 21–0960–L–1—20,000 (o) VAF 21–0960–N–3—5,000 (p) VAF 21–0960–N–4—20,000 (q) VAF 21–0960–Q–1—10,000 Dated: August 25, 2014. By direction of the Secretary. Crystal Rennie, VA Clearance Officer, Department of Veterans Affairs. [FR Doc. 2014–20472 Filed 8–27–14; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Research Advisory Committee on Gulf War Veterans’ Illnesses; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App.2 that the Research Advisory Committee on Gulf War Veterans’ PO 00000 Frm 00106 Fmt 4703 Sfmt 9990 Illnesses will meet on September 22 and 23, 2014, in the greater Washington, DC, area. On Monday, September 22, the meeting will be held in 810 Vermont Avenue NW., Room 230, Washington, DC, from 9:00 a.m. until 5:15 p.m. On Tuesday, September 23, the meeting will be held at the VHA National Conference Center, 2011 Crystal Drive, Suite 150, Arlington, Virginia from 9:00 a.m. until 1:00 p.m. All sessions will be open to the public, although space will be limited on September 23. For interested parties who cannot attend in person, there will be a toll-free telephone number. The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on proposed research studies, research plans, and research strategies relating to the health consequences of military service in the Southwest Asia theater of operations during the Gulf War. The Committee will review VA program activities related to Gulf War Veterans’ illnesses, and updates on relevant scientific research published since the last Committee meeting. Presentations on September 22 will include updates on the VA Gulf War Research Program, followed by research presentations on a treatment for pain, neuroimaging in Gulf War Veterans, and drug trials in animal models. The Committee will devote September 23 to a discussion of Committee activities. The meeting will include time reserved for public comments on both days in the afternoon. A sign-up sheet for 5-minute comments will be available at the meeting. Individuals who wish to address the Committee may submit a 1– 2 page summary of their comments for inclusion in the official meeting record. Members of the public may also submit written statements for the Committee’s review to Dr. Roberta White at rwhite@ bu.edu. Because the meeting is being held in a government building, a photo I.D. must be presented as part of the clearance process. Therefore, any person attending should allow an additional 15 minutes to complete this process before the meeting begins. Any member of the public seeking additional information should contact Dr. White, Scientific Director, at (617) 638–4620 or Dr. Victor Kalasinsky, Designated Federal Officer, at (202) 443–5682. Dated: August 25, 2014. Rebecca Schiller, Committee Management Officer. [FR Doc. 2014–20484 Filed 8–27–14; 8:45 am] BILLING CODE P E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 79, Number 167 (Thursday, August 28, 2014)]
[Notices]
[Page 51400]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20484]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research Advisory Committee on Gulf War Veterans' Illnesses; 
Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. App.2 that the Research 
Advisory Committee on Gulf War Veterans' Illnesses will meet on 
September 22 and 23, 2014, in the greater Washington, DC, area. On 
Monday, September 22, the meeting will be held in 810 Vermont Avenue 
NW., Room 230, Washington, DC, from 9:00 a.m. until 5:15 p.m. On 
Tuesday, September 23, the meeting will be held at the VHA National 
Conference Center, 2011 Crystal Drive, Suite 150, Arlington, Virginia 
from 9:00 a.m. until 1:00 p.m. All sessions will be open to the public, 
although space will be limited on September 23. For interested parties 
who cannot attend in person, there will be a toll-free telephone 
number.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on proposed 
research studies, research plans, and research strategies relating to 
the health consequences of military service in the Southwest Asia 
theater of operations during the Gulf War.
    The Committee will review VA program activities related to Gulf War 
Veterans' illnesses, and updates on relevant scientific research 
published since the last Committee meeting. Presentations on September 
22 will include updates on the VA Gulf War Research Program, followed 
by research presentations on a treatment for pain, neuroimaging in Gulf 
War Veterans, and drug trials in animal models. The Committee will 
devote September 23 to a discussion of Committee activities.
    The meeting will include time reserved for public comments on both 
days in the afternoon. A sign-up sheet for 5-minute comments will be 
available at the meeting. Individuals who wish to address the Committee 
may submit a 1-2 page summary of their comments for inclusion in the 
official meeting record. Members of the public may also submit written 
statements for the Committee's review to Dr. Roberta White at 
rwhite@bu.edu.
    Because the meeting is being held in a government building, a photo 
I.D. must be presented as part of the clearance process. Therefore, any 
person attending should allow an additional 15 minutes to complete this 
process before the meeting begins. Any member of the public seeking 
additional information should contact Dr. White, Scientific Director, 
at (617) 638-4620 or Dr. Victor Kalasinsky, Designated Federal Officer, 
at (202) 443-5682.

    Dated: August 25, 2014.
Rebecca Schiller,
Committee Management Officer.
[FR Doc. 2014-20484 Filed 8-27-14; 8:45 am]
BILLING CODE P